Global Clinical Trials Market 2022-2028
Clinical trials are a type of research that studies new tests and treatments and evaluates their effects on human health outcomes. People volunteer to take part in clinical trials to test medical interventions including drugs, cells and other biological products, surgical procedures, radiological procedures, devices, behavioural treatments and preventive care. Garnering a CAGR of 5.3% from 2022 to 2028, the global clinical trials market is projected to reach worth of USD 52,794 million by 2028-end, according to a new report by Gen Consulting Company.
The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global clinical trials market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the clinical trials industry.
This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the indication, phase, and region. The global market for clinical trials can be segmented by indication: autoimmune, cardiovascular, CNS condition, diabetes, obesity, oncology, pain management, others. Clinical trials market is further segmented by phase: phase I, phase II, phase III, phase IV. Based on region, the clinical trials market is segmented into: Asia-Pacific, Europe, North America, Middle East and Africa (MEA), South America.
By indication:
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook